Iantrek, Inc.
Clinical trials sponsored by Iantrek, Inc., explained in plain language.
-
New glaucoma surgery aims to drain eye fluid and save sight
Disease control ENROLLING_BY_INVITATIONThis study looks at how well a new type of eye surgery, called bio-reinforced canaloplasty, works for people with open-angle glaucoma. The surgery helps drain fluid from the eye to lower pressure. Researchers will follow 300 patients for two years to see how much their eye pressu…
Sponsor: Iantrek, Inc. • Aim: Disease control
Last updated May 17, 2026 10:39 UTC
-
New eye surgery for glaucoma under the microscope: will it lower pressure Long-Term?
Disease control ENROLLING_BY_INVITATIONThis study follows 300 adults with open-angle glaucoma who had a surgery called CycloPen to lower pressure inside the eye. Researchers will track eye pressure, use of glaucoma drops, and any side effects for 24 months after the procedure. The goal is to see if the surgery safely …
Sponsor: Iantrek, Inc. • Aim: Disease control
Last updated May 17, 2026 10:37 UTC
-
Glaucoma surgery patients tracked for five years in new study
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how well a new glaucoma surgery works over five years. Researchers will check eye pressure in 250 people who already had the surgery. The goal is to see if the pressure stays low long-term without needing extra procedures.
Sponsor: Iantrek, Inc. • Aim: Knowledge-focused
Last updated May 12, 2026 13:40 UTC